By Editor , 11 September 2026
BFA Law Probes Coastal Financial Over CCBX Credit Disclosures

Everett, Washington – September 10, 2026 -- Bleichmar Fonti & Auld LLP has opened a securities fraud investigation into Coastal Financial Corp. (NASDAQ:CCB) after the bank's stock plunged 43.5% following disclosure of a massive credit loss tied to its banking-as-a-service partnerships.

Coastal Financial's stock collapsed 43.5% in a single trading session on July 30, 2026

Shares fell $30.75, from a close of $70.66 on July 29, 2026, to $39.91 the following day, after the company released Q2 2026 results.

By Editor , 11 September 2026
Capricor Sued Over Deramiocel Data After 64.5% Stock Collapse

New York – September 10, 2026 -- Capricor Therapeutics, Inc. (NASDAQ:CAPR) faces a securities fraud class action after its shares plunged 64.5% following disclosures about alleged undisclosed changes to clinical trial statistics underlying its Duchenne muscular dystrophy therapy application.

By Editor , 11 September 2026
UWM Holdings Sued Over Hedging Losses Tied to Failed Two Harbors Deal

New York – September 10, 2026 -- UWM Holdings Corporation (NYSE:UWMC) faces a securities fraud class action after its stock plunged 34.78% on August 6, 2026, following disclosures about an over-hedged mortgage servicing rights position tied to a collapsed $1.3 billion merger with Two Harbors Investment Corp.

By Editor , 11 September 2026
York Space Systems Sued Over Satellite Software Claims After 10.9% Stock Drop

New York – September 10, 2026 -- A class action lawsuit has been filed against York Space Systems Inc. (NYSE:YSS) and several senior executives following a 10.9% single-day stock decline tied to allegations the company misrepresented the capabilities of its proprietary satellite software.

By Editor , 11 September 2026
Innventure Sued Over 55% Stock Drop Tied to DarkNX Data Center Deal

New York City – September 10, 2026 -- Innventure, Inc. (NASDAQ:INV) faces a securities fraud class action after its stock collapsed 55% on August 14, 2026, following disclosures that its subsidiary Accelsius had pulled a marquee data center project from its bookings.

By Editor , 11 September 2026

Gothenburg – – September 10, 2026 -- Epicyt Pharma AB reported positive topline results from a Phase 1/2a first-in-human study of its oral drug candidate BAFA, showing a statistically significant reduction in urinary calcium excretion in patients who underwent Roux-en-Y gastric bypass (RYGB) surgery. The Gothenburg-based clinical-stage biopharmaceutical company said the trial, completed in March 2026, also recorded improvements in key biomarkers of calcium homeostasis, consistent with enhanced intestinal calcium uptake.

By Editor , 11 September 2026

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP (SBS) has issued a reminder to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a securities class action lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lead plaintiff deadline is set for September 28, 2026.

By Editor , 11 September 2026

Los Angeles -- Shareholders of Pentair plc (NYSE: PNR) have until October 2, 2026 to seek lead plaintiff status in a securities fraud class action filed against the water treatment and pool equipment manufacturer, according to Schall, Brown & Schwartz LLP (SBS).